Pittsburgh, Pennsylvania Saturday, May 24, 2025, 15:00 Hrs [IST] ...

To fully realize the benefits of GenAI and leverage it successfully, it’s crucial to develop strategies that harness its full ...

It’s reported that Apple plans to open its on-device AI models to developers at WWDC 2025, aiming to boost app creation and ...

We recently published a list of Jim Cramer Reveals “Quiet” Stock That Goes Up In This List Of 12 Stocks. In this article, we ...

We recently published a list of Jim Cramer Reveals “Quiet” Stock That Goes Up In This List Of 12 Stocks. In this article, we ...

In a recent appearance on CNBC’s Squawk on the Street, Jim Cramer commented on the recent downgrade of US credit. In a surprising development that led markets to end flat during ...

Company Leverages More Than Twenty Years of Drug Response Data Derived from Massive Biobank of Live Cell Tumor ...

Although still in its infancy, this technology has already shown remarkable effectiveness in detecting and treating cancer, ...

Artificial intelligence and robotics are revolutionizing drug discovery by automating laboratory processes and enabling rapid, data-driven breakthroughs. This hybrid approach is cutting costs, ...

Regeneron Pharmaceuticals Inc. (NASDAQ:REGN) announced Monday that it has secured the winning bid in the bankruptcy auction ...

We spoke with Google Brain and Coursera co-founder Andrew Ng about his AI Fund, focusing on building companies from scratch ...

Regeneron acquired 23andMe for $256M, gaining 15M DNA profiles to enhance R&D. Find out why REGN stock is a Buy.